AKRO – akero therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Akero Therapeutics (NASDAQ:AKRO) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO
Halper Sadeh LLC Encourages WOW, AKRO, HFWA, BRY Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights
Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)
Form 25-NSE Akero Therapeutics, Inc. Filed by: Nasdaq Stock Market LLC
Form 4 Akero Therapeutics, Inc. For: Dec 09 Filed by: Heyman Tomas J.
Form 4 Akero Therapeutics, Inc. For: Dec 09 Filed by: Xu Yuan
Form 4 Akero Therapeutics, Inc. For: Dec 09 Filed by: Cheng Andrew
Form 4 Akero Therapeutics, Inc. For: Dec 09 Filed by: Harrison Seth Loring
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.